Send to a Friend Font Size: Increase Decrease

MCRB and BCYC Related Headlines

Mar 2, 2026 04:06PM Seres Therapeutics names Richard Kender as interim CEO
Mar 2, 2026 04:05PM Seres Therapeutics Announces Appointment of Richard N. Kender as Executive Chair and Interim CEO; Provides Business Updates

MCRB and BCYC Related Press Releases

Mar 2, 2026 04:05PM Seres Therapeutics Announces Appointment of Richard N. Kender as Executive Chair and Interim CEO; Provides Business Updates

MCRB and BCYC Related SEC Filings